Differential expression analysis showed robust upregulation of <i>MNX1</i>-<i>AS1</i> in resistant cells and tumor tissues, accompanied by correlations with epithelial-mesenchymal transition (EMT)-related transcription factors such as <i>FOXA1</i> and <i>SNAI2</i> and inverse associations with epithelial markers including <i>CDH1</i>. The gene discussed is SNAI2; the disease is neoplasm.